Microchip technology incorporated (MCHP)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Dec'09Sep'09Jun'09
Cash flows from operating activities:
Net income

99,900

311,100

108,900

50,700

174,700

49,200

96,300

35,700

146,700

-251,000

189,100

170,600

136,869

107,175

33,919

-113,363

67,330

61,211

64,899

130,460

98,580

84,798

92,038

89,909

111,495

105,401

99,806

78,579

59,690

10,173

-21,184

78,710

80,636

77,489

79,287

99,293

125,528

100,776

103,080

89,566

75,749

69,403

44,485

27,368

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization

310,900

300,000

297,600

307,100

238,700

243,900

221,000

172,800

156,900

154,600

152,600

151,800

128,275

114,968

112,816

113,141

75,538

76,178

71,109

60,375

73,186

73,303

70,821

60,988

45,435

45,242

48,052

50,410

63,629

64,012

51,211

25,245

24,254

24,642

25,177

25,351

26,459

27,177

27,537

25,439

22,322

22,437

22,639

22,659

Deferred income taxes

-86,100

-293,300

-94,100

-16,800

-33,100

42,500

-158,800

87,200

-16,400

114,500

-25,000

-21,900

-74,685

-34,395

-50,726

32,906

-49,284

24,883

-18,490

-17,509

-38,606

10,292

-2,178

-2,319

-18,869

12,318

6,574

5,298

-18,387

-556

-12,352

2,927

14,769

99

358

6,728

6,623

4,086

4,221

9,073

4,775

11,294

-910

7,171

Share-based compensation expense related to equity incentive plans

40,700

43,500

45,300

40,700

38,900

39,600

42,600

45,300

23,200

24,000

23,600

22,400

22,011

22,120

24,390

59,579

17,297

16,965

23,026

14,112

15,183

14,819

15,273

13,321

12,412

13,719

15,000

12,656

13,356

14,120

14,607

9,986

9,819

9,962

9,484

9,024

9,027

9,409

8,925

9,451

9,443

8,837

9,500

8,998

Excess tax benefit from share-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

65

328

144

263

116

118

982

0

1,411

0

0

0

143

42

92

20

135

39

17

385

614

1,240

0

0

-

-

-

-

Loss on settlement of debt

-3,400

0

-100

-1,900

-8,300

-200

-4,100

0

0

-2,200

0

-13,800

-43,900

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible debt derivatives - revaluation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

201

264

-16

115

336

-259

-330

223

-61

-396

30

-7

249

-156

99

-384

2

305

-153

Amortization of Debt Discount (Premium)

30,800

30,700

30,300

29,900

29,400

28,900

28,600

27,700

27,100

26,700

26,400

25,900

19,193

12,494

12,307

12,106

12,091

12,163

11,974

11,772

7,480

2,501

2,445

2,365

2,288

2,286

2,235

2,161

2,091

2,089

2,042

1,975

1,932

1,909

1,866

1,805

1,746

1,745

1,706

1,650

1,596

1,595

1,559

1,508

Amortization of Debt Issuance Costs

4,300

4,300

4,300

4,200

4,400

4,600

4,700

2,800

1,600

1,700

1,700

1,600

1,318

1,064

1,061

1,057

1,084

996

962

958

831

544

544

544

543

544

545

327

53

55

55

54

54

55

55

55

54

55

55

55

-87

55

193

54

Losses on equity method investments

0

0

0

0

0

-100

0

-100

0

-100

0

-100

-33

-55

-56

-56

-11

-56

-56

-177

-188

-62

-35

-32

34

150

-101

-260

-235

-229

-32

-121

-135

14

-13

-61

-28

280

-43

-52

0

0

0

0

Gains on sale of assets

-

-

-

-

-

-

-

-

500

0

800

4,600

22

3

14

61

40

100

300

560

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

0

50

-49

88

200

-100

0

0

Impairment of Intangible Assets (Excluding Goodwill)

1,700

0

0

500

0

0

1,100

2,000

200

100

100

100

1,674

8,242

0

1,984

23

47

530

0

20

1,305

150

406

0

0

350

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of available-for-sale investments

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Losses on write-down of fixed assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-961

-48

-269

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Gains) losses on available-for-sale investments and marketable equity securities, net

-

-

-

800

-

-

-

-5,200

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Realized losses (gain) on available-for-sale investments

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-7

-82

-354

95

-41

14,000

18,469

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Realized gain on equity method investment

-

-

-

-

-

-

-

-

-

-

-

-

-68

0

0

468

-25

0

0

2,225

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of premium on available-for-sale investments

0

0

0

0

0

0

0

200

200

100

-100

-500

5

-5

13

-13

-1,770

-2,498

-2,336

-2,396

-2,388

-2,495

-2,477

-2,589

-2,687

-2,499

-2,627

-2,941

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other non-cash adjustment

-

-

-

-100

-

-

-

-100

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-540

762

1,629

-1,392

-4,400

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized impairment loss on available-for-sale investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,055

-204

-2,064

-945

-3,396

-422

-388

-453

-6,920

528

376

1,266

Sales of trading securities, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

31,755

55,215

Special charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

1,238

Gain on shares of acquired company

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

14,850

0

-1,940

-5,485

Changes in operating assets and liabilities, excluding impact of acquisitions:
(Increase) decrease in accounts receivable

126,500

-41,100

-88,300

56,200

-49,400

-124,000

-120,600

55,200

10,500

7,800

16,400

50,600

3,249

18,119

15,531

9,901

42,127

-34,857

-8,266

3,096

31,342

-44,878

-7,818

37,247

18,132

-6,317

-1,769

2,462

52,453

-52,955

-2,698

2,814

20,080

6,868

-53,845

15,052

-9,357

-15,487

9,255

9,248

74,316

-7,112

-8,607

-9,519

Decrease (increase) in inventories

-23,200

-25,800

-300

20,500

2,900

-83,000

-177,700

-83,800

-11,000

30,100

30,200

9,900

-3,026

-4,724

-94,848

-121,102

-13,427

-39,370

-19,296

23,893

3,167

3,368

-7,061

-24,991

-12,088

-1,515

18,146

13,957

-18,721

-24,812

-22,018

-316

-1,057

6,223

8,690

21,384

1,289

10,744

5,716

4,319

-34,455

-3,834

5,346

17,704

Increase in deferred income on shipments to distributors

-

-

-

-

-

-

-

-

-1,900

11,400

15,500

16,000

-1,427

71,063

10,025

29,739

19,888

-16,380

12,091

1,401

11,864

-5,321

13,002

-1,215

4,483

-7,734

1,232

10,865

16,341

-511

953

2,084

-7,077

-28,399

-1,413

5,554

-2,641

10,403

24,212

6,807

1,358

11,322

2,830

-500

Increase (decrease) in accounts payable and accrued liabilities

64,700

-44,900

-58,100

49,700

-37,200

-105,700

-35,600

-2,200

-55,700

15,900

-5,300

31,200

7,461

-244

-4,017

-18,000

18,034

-12,991

-47,600

16,157

5,009

-23,184

-11,402

-4,415

10,237

-19,864

-5,915

3,909

17,625

-30,869

-32,436

4,766

5,743

-16,898

-32,513

-17,787

18,641

-22,607

1,844

1,484

14,983

3,463

18,329

-7,192

Change in other assets and liabilities

9,200

3,000

15,300

-14,400

39,400

-40,300

-63,500

88,600

1,500

-16,200

-12,300

13,000

-44,480

5,139

1,371

12,270

-27,199

33,688

-1,364

-5,225

-4,773

18,453

5,056

-15,839

-38,886

10,392

-5,214

-14,977

43

-73,462

35,171

5,291

-23,110

1,123

24,890

-10,873

-43,785

4,287

884

3,042

3,094

-15,622

2,874

-5,265

Change in income tax payable

18,000

-22,900

-11,500

-24,100

-27,300

-70,200

-79,400

-13,900

64,000

286,500

6,400

11,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating cash flows related to discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-48

-966

4,318

5,996

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net cash provided by operating activities

371,700

395,500

396,000

380,600

403,400

481,500

487,500

302,400

359,500

365,000

350,100

345,000

322,608

290,802

222,123

223,967

202,509

210,477

149,886

181,528

178,510

184,838

192,046

165,788

203,341

148,300

157,551

167,372

127,883

139,211

63,300

128,971

117,980

55,939

154,754

83,305

152,537

138,677

158,129

133,318

108,028

100,927

128,025

115,067

Cash flows from investing activities:
Purchases of available-for-sale investments

0

2,000

0

0

0

0

0

167,700

256,700

458,700

392,000

487,400

465,153

35,122

0

25

31,036

430,775

541,588

570,501

237,457

371,263

178,092

172,506

386,922

234,795

336,364

379,401

342,249

213,622

413,976

29,130

187,026

296,404

340,822

324,893

148,749

62,430

553,668

243,209

264,098

760,552

418,115

133,279

Maturities of available-for-sale investments

0

0

0

0

2,300

-200

9,200

66,700

266,700

157,000

253,000

110,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Sales of available-for-sale investments and marketable equity securities

4,700

0

0

0

0

0

0

1,376,600

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Sales and maturities of available-for-sale investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

470,551

-

397,716

362,325

433,446

275,905

274,123

225,834

321,203

367,110

213,380

188,192

182,614

338,872

167,114

211,154

139,439

190,262

230,793

297,960

264,485

216,291

145,235

367,860

325,900

418,981

551,112

317,067

214,967

Sale of equity method investment

-

-

-

-

-

-

-

-

-

-

-

-

1,232

0

0

468

33

0

0

2,667

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments to Acquire Businesses, Net of Cash Acquired

0

0

0

0

0

0

-600

7,851,200

0

0

0

0

-2,747,516

0

0

2,747,516

343,900

0

0

0

0

0

-375,365

375,365

0

0

0

0

-20,556

0

0

20,556

38,580

0

0

0

-99,687

0

0

112,707

0

0

0

0

Investments in other assets

31,000

26,900

11,000

2,600

5,800

3,900

7,300

1,600

1,700

1,600

1,800

2,000

603

6,365

2,467

765

1,139

2,980

1,215

1,766

1,389

1,615

2,536

1,123

1,607

4,511

1,335

1,616

712

1,814

595

1,609

-1,060

1,732

4,170

976

1,724

13,410

1,291

142

9,464

1,082

3,991

902

Acquisition of ISSC, net of cash acquired

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-11,187

9,013

0

2,174

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of additional controlling interest in ISSC

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-51

0

0

18,051

9,161

21,169

1,765

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of assets

2,700

0

300

200

0

100

0

100

0

100

0

10,200

-69

23,003

14

52

4

0

13,669

627

0

0

0

0

35

0

0

16,200

0

240

16

50

199

164

48

0

1,109

2,129

10,000

18,430

0

100

0

0

Capital expenditures

11,900

14,100

17,700

23,900

40,100

27,400

72,000

89,400

58,400

66,400

59,800

22,200

22,962

15,692

18,152

18,494

16,477

17,869

29,943

33,611

29,458

36,642

38,735

44,637

33,536

24,330

27,449

27,757

14,742

9,864

15,908

10,304

3,788

6,133

25,230

27,219

24,340

34,177

31,834

34,103

19,188

18,683

5,977

3,756

Net cash used in investing activities

-35,500

-43,000

-28,400

-26,300

-43,600

-31,400

-69,500

-6,666,500

-50,100

-369,600

-200,600

-391,400

-487,504

-34,176

-20,591

-2,295,729

1,582,177

-53,908

-540,680

-187,189

-1,560

-156,566

-247,763

-272,428

-54,920

-59,269

-176,956

-212,134

-18,831

-57,946

-951,055

77,890

-37,873

-73,312

-72,214

-88,603

29,567

37,347

-208,933

-45,831

67,829

-229,105

-111,016

77,030

Cash flows from financing activities:
Proceeds from issuance of 2023 and 2021 Senior Notes

0

0

0

0

0

0

0

1,989,500

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayments of revolving loan under previous credit facility

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

650,000

-

50,000

80,000

0

-

-

-

-

-

-

-

-

-

-

-

-

Repayments of revolving loan under new credit facility

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

83,500

70,000

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from borrowings on revolving loan under previous credit facility

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

30,000

-

60,000

680,000

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from borrowings on Term Loan Facility

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

350,000

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from borrowings on loan facility

-

-

-

-

-

-

-

-

-

74,000

53,000

60,000

-

132,000

105,000

1,280,000

1,087,000

93,000

879,500

145,000

1,087,319

139,400

128,500

504,375

300,000

93,500

100,000

260,000

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Repayments of long-term borrowings

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

336,875

4,375

4,375

4,375

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayments of loan facility

-

-

-

-

-

-

-

-

-

74,000

53,000

60,000

-

127,000

349,500

602,000

-

381,000

80,000

110,000

-

119,400

138,500

170,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayment of debt assumed in Microsemi acquisition

0

0

0

0

0

0

0

2,056,900

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred financing costs

7,100

0

1,800

0

0

0

100

72,600

0

400

800

0

-

-

-

-

44

1,750

0

406

32,846

0

0

0

0

0

0

7,515

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Payment of cash dividends

88,000

87,700

87,300

87,100

86,600

86,400

85,900

85,500

85,100

85,000

84,500

82,900

82,553

77,970

77,640

77,237

73,161

72,923

72,685

72,331

72,047

71,787

71,442

71,202

70,882

70,554

70,086

69,682

69,230

68,697

68,146

67,749

67,259

66,813

66,206

65,900

3

129,447

63,908

63,453

62,962

62,520

62,083

61,991

Proceeds from sale of common stock

20,000

11,300

20,200

7,300

15,700

6,600

13,900

6,400

15,400

7,000

15,100

4,500

13,307

3,441

20,822

4,630

10,784

4,396

10,023

3,497

13,604

6,794

9,910

4,125

17,569

9,629

20,274

12,614

28,746

6,301

11,357

4,961

17,047

14,743

7,395

18,272

20,593

29,078

14,959

7,310

17,900

9,603

8,431

544

Tax payments related to shares withheld for vested restricted stock units

17,900

23,600

15,200

11,400

14,800

20,100

20,100

16,800

10,300

12,900

10,500

10,700

10,239

12,318

10,660

25,183

4,499

6,077

6,660

4,464

5,228

3,970

5,338

4,968

4,875

7,073

4,978

5,714

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Capital lease payments

200

200

200

200

200

200

300

100

200

200

200

200

213

196

196

195

96

170

168

166

154

152

150

148

141

135

134

44

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Excess tax benefit from share-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-35

328

144

263

116

118

982

0

1,411

0

0

0

143

42

92

20

135

39

17

385

614

1,240

0

0

-

-

-

-

Net cash (used in) provided by financing activities

-332,300

-357,200

-399,800

-348,900

-363,400

-477,600

-593,500

6,098,000

-80,200

-149,700

-96,100

-89,300

409,702

-82,043

-312,174

580,015

-23,422

-364,196

366,325

-38,607

-25,474

-53,372

-80,413

257,807

-56,918

-58,133

-39,624

-80,341

-46,011

-52,354

543,303

-62,768

-50,077

-52,031

-58,794

-47,243

21,204

-99,129

-48,949

-56,143

-45,018

-51,576

-52,943

-61,447

Effect of foreign exchange rate changes on cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

7

-633

104

-478

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net decrease in cash and cash equivalents

3,900

-4,700

-32,200

5,400

-3,600

-27,500

-175,500

-266,100

229,200

-154,300

53,400

-135,700

244,813

173,950

-110,538

-1,492,225

1,761,264

-207,627

-24,469

-44,268

151,476

-25,100

-136,331

151,167

91,503

30,898

-59,029

-125,103

63,041

28,558

-343,113

144,093

30,030

-69,404

23,746

-52,541

203,308

76,895

-99,753

31,344

130,839

-179,754

-35,934

130,650

Non-cash activities:
Right-of-use assets obtained in exchange of lease liabilities

-300

7,800

17,300

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease payments in operating cash flows

7,200

26,200

-1,700

14,800

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Term Loan Facility
Proceeds from borrowings on loan facility

0

0

0

0

0

0

0

3,000,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayments of loan facility

0

0

0

188,000

801,500

20,000

267,000

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revolving Credit Facility
Proceeds from borrowings on loan facility

344,000

255,000

223,000

204,000

691,000

93,000

147,000

3,485,500

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayments of loan facility

580,000

512,000

538,500

273,500

167,000

450,500

381,000

151,500

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-